Special Focus Session
SF 15b - Update on interstitial lung disease
Lectures
1
Chairperson's introduction
04:00Anand Devaraj, London / UK
2
Interstitial lung abnormalities (ILAs): what are they, and what should we do?
20:00Mariana Benegas Urteaga, Barcelona / ES
3
CT imaging of connective tissue disease ILD
20:00Lisa Jungblut, Zurich / CH
4
Imaging of pulmonary toxicity from systemic cancer therapy
20:00Guillaume Chassagnon, Paris / FR
5
CT imaging of hypersensitivity pneumonitis
18:00Judith Babar, Cambridge / UK
6
Panel discussion: The link between ILAs and ILD
08:00Panel discussion: The link between ILAs and ILD
4 min
Chairperson's introduction
Anand Devaraj, London / United Kingdom
20 min
Interstitial lung abnormalities (ILAs): what are they, and what should we do?
Mariana Benegas Urteaga, Barcelona / Spain
- To understand the definition of ILAs.
- To appreciate how and when to report CTs with ILAs.
- To understand the clinical significance of ILAs.
20 min
CT imaging of connective tissue disease ILD
Lisa Jungblut, Zurich / Switzerland
- To understand the typical and atypical CT features of CTDs.
- To appreciate the clinical significance of CT markers of disease severity in CTD.
- To understand the impact of technological developments in CTD imaging with CT.
20 min
Imaging of pulmonary toxicity from systemic cancer therapy
Guillaume Chassagnon, Paris / France
- To appreciate the different patterns of pulmonary toxicity on CT.
- To be aware of key systemic cancer therapies that cause pulmonary toxicity.
- To develop knowledge on how to optimally report CT findings of pulmonary toxicity.
18 min
CT imaging of hypersensitivity pneumonitis
Judith Babar, Cambridge / United Kingdom
- To be aware of the classifications of hypersensitivity pneumonitis and the role of imaging.
- To understand the important diagnostic and prognostic CT features of hypersensitivity pneumonitis.
8 min
Panel discussion: The link between ILAs and ILD